Last updated: 11/03/2018 16:56:28
Epidemiologic study to evaluate the proportion of cardiovascular disease Risk Factors in Korean hypertensive patientsWONDeR
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Finalized
Finalized
Trial overview
Official title: A multi-center, observational, cross-sectional study to evaluate CVD risk factors in Korean hypertensive patients
Trial description: The purpose of this study is investigating the proportion of Cardiovascular disease risk factors of hypertensive patients.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Proportion of patients with cardiovascular disease high risk factors
Timeframe: 6years, average duration of hypertension
Secondary outcomes:
Proportion of patients with Cardiovascular disease risk factors
Timeframe: 6years, average duration of hypertension
Proportion of patients with Cardiovascular disease
Timeframe: 6years, average duration of hypertension
Target Blood Pressure achievement rate according to the proportion of Cardiovascular disease risks
Timeframe: 6years, average duration of hypertension
Interventions:
Other: Blood Sampling
Enrollment:
3109
Observational study model:
Other
Primary completion date:
Not applicable
Time perspective:
Cross-Sectional
Clinical publications:
Not applicable
Medical condition
Hypertension
Product
Not applicable
Collaborators
Not applicable
Study date(s)
August 2010 to January 2011
Type
Observational
Phase
Not applicable
Participation criteria
Sex
Female & Male
Age
18+ years
Accepts healthy volunteers
No
- Essential hypertensive patient no less than 18 yeas old
- Patient who gave informed consent form
- Patient was diagnosed as secondary hypertension
- Patient who have white-coat hypertension
Inclusion and exclusion criteria
Inclusion criteria:
- Essential hypertensive patient no less than 18 yeas old
- Patient who gave informed consent form
Exclusion criteria:
- Patient was diagnosed as secondary hypertension
- Patient who have white-coat hypertension
Trial location(s)
No location data available.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Finalized
Actual primary completion date
Not applicable
Actual study completion date
2011-17-01
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website